在医疗耐药性中神经刺激:不良影响和临床相关性
Khaled A Alshehri1, Shaima H Abuhulayqah1, Mohammed A Asiry1
1From the Neuroscience Center (Alshehri, Abuhulayqah, Asiry, Alyamani), King Faisal Specialist Hospital and Research Center, Riyadh, and from the Department of Medicine (Alshehri), Faculty of Medicine, Tabuk University, Tabuk, Kingdom of Saudi Arabia.
Neurosciences (Riyadh, Saudi Arabia)
|January 9, 2024
概括
迷你神经刺激 (VNS) 是一种有效的治疗方法,但可能会出现不良反应,如和呼吸障碍. 某些患者因素增加了这些副作用的风险,影响了治疗的继续.
科学领域:
- 神经学 神经学
- 神经外科 神经外科
- 发病学 (Epileptology) 是一个专业的学科.
背景情况:
- 耐药性 (DRE) 对患者管理构成重大挑战.
- 神经刺激 (VNS) 是一种已被确立的DRE的辅助疗法.
- 了解VNS相关的不良影响对于优化患者的治疗结果至关重要.
研究的目的:
- 确定在接受VNS植入的儿科和成人患者中不良反应的发生率.
- 为了确定与VNS相关副作用的风险增加相关的临床变量.
主要方法:
- 对接受VNS植入的DRE患者的回顾性分析.
- 数据收集包括人口统计,特征,设备数据和至少6个月的随访.
- 评估不良事件的频率和严重程度.
主要成果:
- 在43名患者中,32.55%报告没有副作用,而8名患者经历了显著的不良事件.
- VNS治疗的有效性各不相同,其中23.26%的患者在发作频率上没有变化.
- 常见的副作用包括消化不良和呼吸不良,可能导致治疗中止.
结论:
- VNS是的有价值的辅助治疗方法,但需要仔细监测副作用.
- 缺食和呼吸障碍是与VNS相关的重大不良事件,可能导致严重并发症.
- 患有症状普遍性,全身发育迟缓,MRI异常和多发性类病理的患者有更高的副作用风险.
相关概念视频
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
304
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
304
Local Anesthetics: Adverse Effects
416
While local anesthetics are generally safe and well-tolerated, they can occasionally cause adverse effects that vary in severity. Local anesthetics can induce toxicity at two distinct levels. They can either produce local effects through direct contact with the neural elements or be absorbed into the bloodstream from the injection site, leading to systemic effects.
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
416
Seizures: Classification
365
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
365
Electroconvulsive Therapy
41
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
41
Antiepileptic Drugs: GABAergic Pathway Potentiators
406
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
406
Antiepileptic Drugs: Glutamate Antagonists
367
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
367


